Last updated on April 2019

Phase IIb Study of Evobrutinib in Subjects With Rheumatoid Arthritis


Brief description of study

The purpose of the study is to determine the efficacy, dose response, and safety of evobrutinib in subjects with Rheumatoid Arthritis (RA), and to consider a dose to take forward into Phase III development.

Clinical Study Identifier: NCT03233230

Find a site near you

Start Over

Omega Research Consultants

Orlando, FL United States
  Connect »

Medication Management, LLC

Greensboro, NC United States
  Connect »

Organizacion Medica de Investigacion (OMI)

Ciudad Autonoma Buenos Aires, Argentina
  Connect »

APRILLUS

Ciudad Autonoma Buenos Aires, Argentina
  Connect »

Expertia S.A- Mautalen Salud e Investigaci n

Ciudad Autonoma Buenos Aires, Argentina
  Connect »

Hospital General de Agudos Dr. J. M. Ramos Mejia

Ciudad Autonoma Buenos Aires, Argentina
  Connect »

CCBR - Bras lia

Brasília, Brazil
  Connect »

Interin

Santiago, Chile
  Connect »

Servimed S.A.S.

Bucaramanga, Colombia
  Connect »

ARTROSCAN s.r.o.

Ostrava - Trebovice, Czechia
  Connect »

Thomayerova nemocnice

Praha 4 - Krc, Czechia
  Connect »

MEDICAL PLUS s.r.o.

Uherske Hradiste, Czechia
  Connect »

Care Clinic

Katowice, Poland
  Connect »

RCMed

Sochaczew, Poland
  Connect »

Ultramed

Omsk, Russian Federation
  Connect »

Technologii zdorovia LLC

Saint-Petersburg, Russian Federation
  Connect »

LLC Medical Sanitary Unit#157

Saint-Petersburg, Russian Federation
  Connect »

Iatros International

Bloemfontein, South Africa
  Connect »

Wits Clinical Research

Johannesburg, South Africa
  Connect »

Clinresco Centres (Pty) Ltd

Kempton Park, South Africa
  Connect »

Emmed Research

Pretoria, South Africa
  Connect »

Naidoo, A

Durban, South Africa
  Connect »

CI City Hospital #1

Zaporizhzhia, Ukraine
  Connect »

CCBR - Bras lia

Brasília, Brazil
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.